Literature DB >> 7608726

A case of protracted coxsackie virus meningoencephalitis in a marginally immunodeficient child treated successfully with intravenous immunoglobulin.

T J Geller1, D Condie.   

Abstract

A child with acute lymphocytic leukemia who was in clinical remission and developed coxsackie B4 meningoencephalitis is presented. Despite minimal evidence of immunodeficiency, the patient had progression of neurologic disease clinically, electroencephalographically and on laboratory evaluation of spinal fluid. A dramatic response to the use of intravenous immunoglobulins is reported and its rationale explained.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7608726     DOI： 10.1016/0022-510x(94)00261-l

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


  16 in total

Review 1.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

2.  Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.

Authors:  M K Slifka; R Pagarigan; I Mena; R Feuer; J L Whitton
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 3.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

4.  beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis.

Authors:  Karin Klingel; Jens-Jörg Schnorr; Martina Sauter; Gudrun Szalay; Reinhard Kandolf
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

5.  The role of B lymphocytes in coxsackievirus B3 infection.

Authors:  I Mena; C M Perry; S Harkins; F Rodriguez; J Gebhard; J L Whitton
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

6.  Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection.

Authors:  Guo-hui Chang; Yan-jun Luo; Xiao-yan Wu; Bing-yin Si; Lei Lin; Qing-yu Zhu
Journal:  Virol J       Date:  2010-05-26       Impact factor: 4.099

7.  Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors.

Authors:  Nadine Althof; J Lindsay Whitton
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

8.  Enumeration and functional evaluation of virus-specific CD4+ and CD8+ T cells in lymphoid and peripheral sites of coxsackievirus B3 infection.

Authors:  Christopher C Kemball; Stephanie Harkins; J Lindsay Whitton
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

9.  Molecular evidence of persistent echovirus 13 meningoencephalitis in a patient with relapsed lymphoma after an outbreak of meningitis in 2000.

Authors:  Christine Archimbaud; Jean-Luc Bailly; Martine Chambon; Olivier Tournilhac; Philippe Travade; Hélène Peigue-Lafeuille
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

10.  Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection.

Authors:  Xiao Fang Lim; Qiang Jia; Wei Xin Khong; Benedict Yan; Balraj Premanand; Sylvie Alonso; Vincent T K Chow; Jimmy Kwang
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.